“Morgan Stanley Bets on These 3 Stocks; Sees Over 40% Upside”
September 17, 2020
“Akero Therapeutics (AKRO)…
Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target, shares could rise 61% in the next year…
TransDigm Group (TDG)…
Looking at the consensus breakdown, 7 Buys and 5 Holds have been published in the last three months. Therefore, TDG gets a Moderate Buy consensus rating. Based on the $500.58 average price target, shares are poised to stay range-bound for now…
Cemex SAB (CX)…
Turning to the rest of the analyst community, opinions are split almost evenly. 6 Buys and 5 Holds add up to a Moderate Buy consensus rating. At $4.16, the average price target implies 4% upside potential…”
https://finance.yahoo.com/news/morgan-stanley-bets-3-stocks-202534828.html